International Biotechnology Trust’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-130,900
Closed -$9.29M 85
2022
Q1
$9.29M Sell
130,900
-9,000
-6% -$639K 2.1% 19
2021
Q4
$19.3M Sell
139,900
-36,500
-21% -$5.03M 4.3% 6
2021
Q3
$24.5M Hold
176,400
5.91% 5
2021
Q2
$17.1M Hold
176,400
4.52% 8
2021
Q1
$12.1M Sell
176,400
-24,000
-12% -$1.64M 3.19% 13
2020
Q4
$17.2M Buy
200,400
+63,000
+46% +$5.4M 4.69% 7
2020
Q3
$8.93M Buy
137,400
+92,400
+205% +$6.01M 2.88% 13
2020
Q2
$3.12M Buy
+45,000
New +$3.12M 1.04% 23
2019
Q3
Sell
-50,949
Closed -$2.23M 66
2019
Q2
$2.23M Buy
50,949
+20,949
+70% +$917K 0.83% 30
2019
Q1
$1.54M Buy
+30,000
New +$1.54M 0.57% 47